Beacon Display Recognized as a Strategic Supplier by Philips 

On July 23, 2025, Shenzhen Beacon Display Technology Co., Ltd. was officially recognized as a Strategic Supplier by Royal Philips at the company’s 2025 Asia-Pacific Supplier Conference held in Suzhou, China.

Beacon Display’s General Manager Mr. Li Bixiang, Deputy General Manager Mr. Xu Bin, and Deputy Director of International Business Ms. Nie Sha were invited to attend the event. During the conference, they joined a roundtable discussion with Philips’ Global Chief Procurement Officer (CPO) and senior executives to exchange insights on future strategic cooperation and development.

As one of the world’s top three multinational medical technology companies, Philips has maintained a strong partnership with Beacon Display since 2011. Over the past 15 years, Beacon Display has supplied medical monitors and human–machine interface (HMI) solutions across Philips’ product lines, including MRI, Ultrasound, IGT, and CT systems, supporting all Philips manufacturing bases worldwide.

Consistency, stability, and reliability are crucial to the precision of medical imaging displays and HMI products, directly impacting the identification of subtle lesions and the accuracy of clinical operations. As one of China’s earliest pioneers in the medical display industry, Beacon Display has focused on intelligent medical imaging and HMI technology innovation for over 20 years. Its core component design capabilities—such as joysticks and encoders—and system integration expertise have reached internationally advanced levels.

Today, as a leading enterprise in the medical display industry, Beacon Display has established a global presence with three R&D centers and four production sites (Shenzhen, Hangzhou, Shenyang, and Korea), along with multiple overseas business hubs. This enables Beacon Display to provide comprehensive, customized one-stop solutions and a robust R&D, manufacturing, and quality assurance system for its partners worldwide.

Looking ahead, Beacon Display will continue to uphold its commitment to quality and innovation, advancing research and development to deliver products and services that consistently exceed industry standards—creating enduring value for the global medical imaging community.